LV Edge System

Asimov's LV Edge System offers two advanced manufacturing platforms, LV Edge Packaging and LV Edge Producer, designed to address the challenges of lentiviral vector (LVV) production. The system aims to reduce or eliminate GMP plasmids, which in turn lowers costs and supply chain risk.
Down this brochure to explore a comparison of lentiviral vector (LVV) production systems, highlighting how the next-generation LV Edge platforms offer significant advantages over the traditional transient approach. These innovative systems improve upon batch-to-batch consistency, simplify manufacturing, reduce supply chain risk, and increase scalability.
Discover how the fully-stable LV Edge Producer system can eliminate plasmids entirely to enable the greatest scalability and cost savings.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.